Category: Asean

One of European wealth management’s most senior figures joins Titanbay’s group board as Non-Executive Director

LONDON, June 16, 2026 (GLOBE NEWSWIRE) — Titanbay today announced the appointment of Marcel Rohner, Vice-Chairman of UBP SA, Chairman of the Swiss Bankers Association and former Group Chief Executive of UBS AG, as a Non-Executive Director on its group board.

Few figures sit closer to the centre of European wealth management. Rohner led UBS through the global financial crisis as Group CEO from 2007 to 2009. He has served on the Board of Union Bancaire Privée since 2016. Since 2021 he is chairing the Swiss Bankers Association, the body that sets policy and standards for Swiss banking, one of the world’s largest wealth management industries.

His decision to join Titanbay is the clearest signal yet of where the centre of gravity in private markets is moving. European wealth managers are racing to widen client access to alternatives. Asset managers are looking for more efficient routes to the wealth channel. Titanbay sits between the two, on technology built specifically for private markets funds. Everything the industry still does manually or stitches together from service providers, Titanbay runs in one place, on infrastructure it built in-house.

“Marcel is one of the most respected figures in European wealth management, and there are very few people in our industry whose judgement carries more weight,” said Michael Gruener, Co-CEO of Titanbay. “His leadership at UBS, his long tenure on the board of UBP and his five years shaping Swiss banking through the Swiss Bankers Association, give him a vantage point on this industry that almost nobody else has. To have him on our board, helping shape what comes next, is an extraordinary moment for the business. We are fortunate to have him.”

Marcel Rohner said: “Private markets are becoming a core allocation for European wealth clients, but the industry’s infrastructure has not kept up. Titanbay has built something different, technology and operations purpose-made for this asset class, used by serious wealth managers and serious asset managers. I look forward to working with the board as the business moves into its next chapter.”

About Marcel Rohner

Marcel Rohner is Vice-Chairman of the Board of Union Bancaire Privée, Chairman of the Swiss Bankers Association and former Group Chief Executive of UBS AG (2007 to 2009), where he led the bank through the global financial crisis. He is serving as Chairman of the Swiss Bankers Association since 2021, having spent five years shaping policy across Swiss banking, and hands over the role to Giorgio Pradelli at Bankers Day in September 2026. He holds a PhD in Economics from the University of Zurich.

About Titanbay

Titanbay is the only firm that structures, launches, runs, and trades private markets funds in one place, on purpose-built technology that didn’t exist until Titanbay built it.

Asset managers use Titanbay to bring private markets funds to market and run them at scale. Wealth managers access those funds and trade them through the systems they already have. Titanbay’s tech and regulatory infrastructure connects both sides, automating the operational complexity that traditionally fragments the industry.

For more information, visit titanbay.com

Media contact

Danielle Wilde
Head of Marketing, Titanbay
[email protected]

GlobeNewswire Distribution ID 1001187871

Emun Zabihi, CEO of iHerb

iHerb CEO Emun Zabihi was awarded as a 2026 EY Entrepreneur of the Year winner for the Pacific Southwest on 13 June 2026.

IRVINE, Calif., June 15, 2026 (GLOBE NEWSWIRE) — iHerb CEO Emun Zabihi was named an EY US Entrepreneur Of The Year^® 2026 Pacific Southwest Award winner. Zabihi was selected among nearly 1,000 program participants that included 592 finalists across 17 regions competing for the title.

Since becoming CEO in 2021, Zabihi has led iHerb through a period of significant international expansion and innovation. Today, iHerb serves millions of customers worldwide through a sophisticated global eCommerce and fulfillment network built on product authenticity, transparency and customer trust. Under Zabihi’s leadership, the company has strengthened its position as a global wellness eCommerce platform dedicated to helping consumers access high-quality health and wellness products wherever they live.

“This recognition is a testament to the remarkable team members who bring our mission to life every day,” said Zabihi. “As consumer demand for health and wellness continues to grow globally, we remain focused on innovation, customer trust and delivering exceptional experiences that help people live healthy lives.”

Now in its 41st year, the Entrepreneur Of The Year program honors business leaders for their ingenuity, courage and entrepreneurial spirit. It celebrates original founders who bootstrapped their business from inception or raised outside capital to grow their company, transformational CEOs who infused innovation into an existing organization to catapult its trajectory and multigenerational family business leaders who reimagined a legacy business model to strengthen it for the future.

Regional winners were chosen by an independent panel of past winners, top CEOs and business leaders. Judges assessed candidates on long-term value creation, entrepreneurial spirit, purpose-driven commitment, and significant growth and impact.

As a Pacific Southwest award winner, Zabihi will now be considered by the national judges for the Entrepreneur Of The Year 2026 National Awards, which will be presented in November at the annual Strategic Growth Forum^®, where high-growth CEOs, Fortune 1000 executives and investors converge to shape the future of business.

About Entrepreneur Of The Year
Founded in 1986, Entrepreneur Of The Year^® has celebrated more than 11,000 ambitious visionaries who are leading successful, dynamic businesses in the US, and it has since expanded to nearly 60 countries and territories globally.

About iHerb, LLC
iHerb is one of the world’s largest eCommerce retailers specializing in health and wellness, delivering products from approximately 2,000 brands to over 15 million active customers across 180 countries. Supported by a global workforce of nearly 2,000 team members, iHerb combines global scale with a deeply localized experience, offering service in 36 languages, over 80 currencies, and more than 40 local payment methods. iHerb’s sophisticated global supply chain network spans nine climate-controlled fulfillment centers located in the U.S., Asia and the Middle East, providing customers a seamless and reliable shopping experience. Founded in 1996 and based in Irvine, California, iHerb is on a mission to make health and wellness accessible to all. For more information, please visit corporate.iherb.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/68f38e01-d020-42d8-8a40-76c68932ad8c

For media inquiries, please contact:
[email protected]

GlobeNewswire Distribution ID 9746524

Fabian Hodouschek, Head of Certification at the Federal Office for Information Security (BSI), presents the BSI NESAS certificate to Omar Shahdad, Senior Vice President, Operations at Mavenir

Fabian Hodouschek, Head of Certification at the Federal Office for Information Security (BSI), presents the BSI NESAS certificate to Omar Shahdad, Senior Vice President, Operations at Mavenir, recognising Mavenir as the first tier-1 vendor to achieve BSI NESAS certification for a 5G Packet Core network function.

BONN, Germany, June 15, 2026 (GLOBE NEWSWIRE) — Mavenir, the software company building Cloud-Native, AI-by-design mobile networks, today announced to be the first tier-1 telecommunications infrastructure software provider to receive the BSI NESAS certification for a 5G Packet Core network function. The certificate confirms that the Mavenir Network Repository Function (NRF) fulfils the security standard requirements for use as a critical component in public telecommunications networks in Germany.

Fabian Hodouschek, Head of Certification, Federal Office for Information Security (BSI): “By issuing the first BSI NESAS cybersecurity certificate to the manufacturer Mavenir, we make an important contribution to securing Germany’s mobile telecom networks. It is the first certificate for a critical 5G core network component used by operators of public 5G mobile networks in Germany. It confirms that Mavenir’s Network Repository Function, including its development and lifecycle processes, meets the standards of the internationally recognized NESAS security framework. We congratulate Mavenir on this success and welcome the commitment of manufacturers to have their critical core network components certified according to BSI NESAS.”

This initial milestone positions Mavenir at the forefront of regulatory readiness following Germany’s mandatory BSI NESAS certification requirements that took effect on January 1, 2026, under the German Telecommunications Act (TKG) and the BSI Act (BSIG). Mavenir is progressing certification of its full Packet Core and IMS portfolio, with completion targeted by Q3 2026, enabling operators to deploy compliant, secure, and cloud-native network architectures at scale.

Omar Shahdad, Senior Vice President, Operations, Mavenir: “This certification validates Mavenir’s commitment to delivering not only industry-leading 5G software, but software that meets the most rigorous national cybersecurity standards. As regulators across Europe raise the bar for network security, Mavenir is ready.”

The certificate was awarded by the certification body of the Federal Office for Information Security (BSI) of Germany under the BSI NESAS certification scheme, a cybersecurity certification that builds upon the internationally recognized GSMA NESAS security assurance framework. BSI NESAS combines rigorous assessment of product development and lifecycle processes with hands-on security testing of the actual product, setting a high bar for critical network infrastructure.

The BSI NESAS certificate for Mavenir NRF CC 24.4.2 p4 is publicly available on the BSI website: https://www.bsi.bund.de/SharedDocs/Zertifikate_NESAS/NESAS-0007-2026.html?nn=1078814

For more information about the BSI NESAS certification scheme, visit: https://www.bsi.bund.de/dok/nesas-en

About Mavenir
Mavenir is enabling intelligent, automated, programmable networks through the development of telco-first, cloud-native, AI-by-design software solutions for mobile operators. The company’s deep telco domain expertise has been proven through deployments with 300+ operators globally in over 120 countries, which together serve more than 50% of the world’s subscribers. Mavenir combines its deep telco experience with the cloud and IT expertise and data science skillsets essential to solving real customer challenges. Its proven software solutions are AI by design, delivering the AI-native future and operators’ evolution to TechCos. ​For more information, please visit www.mavenir.com

Mavenir PR Contact:
Emmanuela Spiteri
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5374f4bb-25fe-4845-8d74-abb85ef9afa8

GlobeNewswire Distribution ID 9746873

Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseases

ZURICH, June 12, 2026 (GLOBE NEWSWIRE) — As allergic diseases continue to affect hundreds of millions of people worldwide and place growing pressure on healthcare systems, the European Academy of Allergy and Clinical Immunology (EAACI) is calling for a new ambition in global health: Vision Zero, a future free from allergy and asthma burden.

This vision will serve as the central theme of the EAACI Annual Congress 2026, taking place in Istanbul, Türkiye, from 12 to 15 June 2026, where thousands of clinicians, researchers and healthcare professionals will gather to discuss the latest scientific advances and the future of allergy and asthma care.

Rather than accepting allergic and respiratory diseases as an inevitable and increasing public health challenge, EAACI believes that scientific innovation, prevention strategies and coordinated policy action can significantly reduce their impact on individuals, families and societies.

“Vision Zero reflects our determination to move beyond disease management and towards disease prevention and burden reduction,” said María Torres, President of EAACI. “The scientific progress we are witnessing today gives us reason to be ambitious. Through collaboration across research, clinical practice and public health, we can work towards a future where allergy and asthma no longer limit the lives of millions.”

The Congress will showcase emerging research and clinical developments across immunotherapy, environmental and genetic factors, digital health technologies, precision medicine and preventive approaches. Discussions will also address health equity and the need to ensure that advances in allergy and asthma care are accessible to patients worldwide.

Allergic diseases are among the most common chronic conditions globally, with prevalence continuing to rise in many regions. The burden extends beyond healthcare, affecting education, productivity, quality of life and mental wellbeing. Against this backdrop, EAACI’s Vision Zero initiative seeks to encourage long term thinking about what is possible when scientific discovery is matched by effective implementation and policy support.

“The concept of Vision Zero challenges us to think differently,” said André Moreira, EAACI Vice President of Congresses. “It encourages the allergy community to focus not only on treating disease but also on preventing it, reducing its impact and creating healthier environments for future generations.”

Held at the crossroads of Europe and Asia, Istanbul will provide a fitting setting for international collaboration and knowledge exchange. The Congress is expected to bring together experts from across the world to accelerate progress towards a future where allergy and asthma burden is substantially reduced.

About EAACI

The European Academy of Allergy and Clinical Immunology (EAACI) is the leading professional organisation dedicated to excellence in allergy and immunology. EAACI works to improve the health of people affected by allergic diseases through research, education, advocacy and the promotion of high-quality patient care.

Media contact: [email protected]

GlobeNewswire Distribution ID 1001187306